Subscribe To
Djia technical: at the risk of shaping a minor downtrend
Key technical elements are showing signs of bullish exhaustion below the 35,650 resistance. Potential downside mean reversion to test the 50-day movin...
August 14, 2023, 1:41 am
Pds biotechnology: interim data reinforces push towards phase 3 study
PDS Biotechnology has achieved positive results in its phase 2 study of PDS0101 in combination with Merck's Keytruda for HPV16-positive head and neck ...
August 14, 2023, 12:22 am
Global partners lp: gas fuels the potential for future distribution increases
The last five years have shown significant stock growth and increasing distributions. The company's recent focus on expansion and its cyclical nature ...
August 13, 2023, 10:05 pm
3 growth stocks to sell now and 4 to buy instead
Second quarter earnings were a lot better than the first quarter. Inflation is beginning to show signs ...
August 13, 2023, 5:02 pm
Amazon's q2 shows why it's still king, but are ratings upgrades too late?
Many are rushing to upgrade Amazon stock after spectacular Q2 results. One critical cash flow metric turned positive, several segments improved, and a...
August 13, 2023, 5:00 pm
Want lower their prices? show companies that you mean it.
Want lower their prices? show companies that you mean it. Read Full Story The post Want lower their pri...
August 13, 2023, 1:58 pm
Fpis invest in equities on global uncertainty, concerns over china
With this, inflow in the equity market reached Rs 1.26 lakh crore, and the same for debt was at Rs 23,300 crore so far this year, data showed … Read...
August 13, 2023, 1:44 pm
Newlake capital partners: stay the course
NewLake Capital Partners remains a long-term investment opportunity in the growing pot stocks market. Legislation progress and state actions are posit...
August 13, 2023, 12:45 pm
Palantir: this is the inflection point
Palantir's Q2 earnings show continued double-digit growth and the potential for its AI offering to expa...
August 13, 2023, 12:00 pm
H&e equipment services: still undervalued with the potential to provide good returns in the short term
H&E Equipment Services stock has risen 38% in less than three months and is still undervalued. Q2 FY23 results ...
August 13, 2023, 10:16 am
Realty income: bullish on this income play
Realty Income's financial results for Q2 2023 showed improvement year over year, with increased guidance for asset purchases. Revenue increased by 25....
August 13, 2023, 9:00 am
Top marijuana stocks to watch as earnings are released
Marijuana stocks are shown to be the sound investment of the future. Why is this you ask? Well, to begin the cannabis industry is still young and prog...
August 13, 2023, 8:38 am
Stanley black & decker: 60% off, but not a buy
Stanley Black & Decker faces significant challenges with weak sales, declining margins, and economic trends affecting performance. Despite its dividen...
August 13, 2023, 8:25 am
H&r reit: an attractive discount to nav, but it needs to fix two things
H&R REIT's Q2-2023 results show strong growth in same property net operating income and modest growth i...
August 13, 2023, 8:09 am
Northrim bancorp: mildly attractive even though the easy money has been made
Northrim Bancorp has shown a solid recovery, with shares down only 5.8% compared to a 36.6% drop earlier this year. The company has a strong presence ...
August 13, 2023, 8:07 am
Salesforce: generative ai, rising profit margins, share repurchases to boost stock
Salesforce stock is finally trading near 52-week highs. The company is showing resilient revenue growth amidst a tough macro environment, highlighting...
August 13, 2023, 6:47 am
Wood: china is somewhat of a problem
WOOD includes commodity exposures in lumber, pulp, and cyclical exposures in packaging companies. Packaging companies are suffering due to pressure fr...
August 13, 2023, 6:33 am
Ewh: hong kong's deteriorating ex-consumption outlook justifies caution
Hong Kong's economic data has begun to show deterioration. While the consumption rebound theme is playi...
August 13, 2023, 6:31 am
Vertex pharmaceuticals still looks attractive
Vertex Pharmaceuticals' Q2 financials showed strong revenue growth. The company's core portfolio of drugs for cystic fibrosis treatment has additional...
August 13, 2023, 4:55 am
Chemed: still bullish on economic characteristics, but risks shouldn't be overlooked
Chemed Corporation's equity stock has declined since its strong performance in FY'22-'23. The company's Q2 numbers ...
August 13, 2023, 1:17 am